This complex regulation may account for the observed differences between CD276 gene expression and B7‐H3 protein levels in relation to pCR in bladder cancer patients, emphasizing the importance of directly assessing protein expression when investigating potential biomarkers. The gene discussed is CD276; the disease is urinary bladder cancer.